vTv Therapeutics (VTVT) Other Accumulated Expenses (2014 - 2021)

vTv Therapeutics (VTVT) has 8 years of Other Accumulated Expenses data on file, last reported at $155000.0 in Q4 2021.

• For the quarter ending Q4 2021, Other Accumulated Expenses rose 675.0% year-over-year to $155000.0; the trailing twelve-month figure through Dec 2021 stood at $155000.0 (up 675.0% YoY), and the FY2021 full-year result was $155000.0, up 675.0% from the prior year.
• Other Accumulated Expenses advanced to $155000.0 in Q4 2021, from $20000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q4 2017 to a low of $20000.0 in Q4 2020.
• A 5-year average of $300400.0 and a median of $142000.0 in 2018 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses tumbled 86.55% in 2018 and surged 675.0% in 2021, its largest moves.
• Tracing VTVT's Other Accumulated Expenses over 5 years: stood at $1.1 million in 2017, then plunged by 86.55% to $142000.0 in 2018, then retreated by 9.15% to $129000.0 in 2019, then tumbled by 84.5% to $20000.0 in 2020, then surged by 675.0% to $155000.0 in 2021.
• Business Quant data shows VTVT's Other Accumulated Expenses at $155000.0 in Q4 2021, $20000.0 in Q4 2020, and $129000.0 in Q4 2019.